Anixa Biosciences Statistics Share Statistics Anixa Biosciences has 32.21M
shares outstanding. The number of shares has increased by 0.1%
in one year.
Shares Outstanding 32.21M Shares Change (YoY) 0.1% Shares Change (QoQ) 0.04% Owned by Institutions (%) 17.41% Shares Floating 30.46M Failed to Deliver (FTD) Shares 159 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 384.68K, so 1.19% of the outstanding
shares have been sold short.
Short Interest 384.68K Short % of Shares Out 1.19% Short % of Float 1.22% Short Ratio (days to cover) 3.62
Valuation Ratios The PE ratio is -8.89 and the forward
PE ratio is -9.34.
Anixa Biosciences's PEG ratio is
-0.41.
PE Ratio -8.89 Forward PE -9.34 PS Ratio 0 Forward PS n/a PB Ratio 5.58 P/FCF Ratio -15.22 PEG Ratio -0.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Anixa Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 8.54,
with a Debt / Equity ratio of 0.01.
Current Ratio 8.54 Quick Ratio 8.54 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.51M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 144K Effective Tax Rate -1.15%
Stock Price Statistics The stock price has increased by -7.84% in the
last 52 weeks. The beta is 0.44, so Anixa Biosciences's
price volatility has been higher than the market average.
Beta 0.44 52-Week Price Change -7.84% 50-Day Moving Average 3.22 200-Day Moving Average 2.97 Relative Strength Index (RSI) 41.17 Average Volume (20 Days) 141,108
Income Statement
Revenue n/a Gross Profit n/a Operating Income -13.83M Net Income -12.55M EBITDA -12.66M EBIT -12.7M Earnings Per Share (EPS) -0.39
Full Income Statement Balance Sheet The company has 1.27M in cash and 232K in
debt, giving a net cash position of 1.04M.
Cash & Cash Equivalents 1.27M Total Debt 232K Net Cash 1.04M Retained Earnings -240.75M Total Assets 16.98M Working Capital 14.88M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.33M
and capital expenditures 0, giving a free cash flow of -7.33M.
Operating Cash Flow -7.33M Capital Expenditures n/a Free Cash Flow -7.33M FCF Per Share -0.23
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ANIX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ANIX is $10,
which is 240.1% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 240.1% Analyst Consensus Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 26, 2015. It was a
backward
split with a ratio of 1:25.
Last Split Date Jun 26, 2015 Split Type backward Split Ratio 1:25
Scores Altman Z-Score 5.96 Piotroski F-Score 1
